LUND, Sweden, Sept. 2, 2019 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that by virtue of the authorisation by the annual general meeting held on 22 May 2019, the board of directors of Hansa Biopharma AB (publ) has resolved to issue and immediately thereaft

WEXFORD, Ireland, Sept. 2, 2019 /PRNewswire/ -- The world famous medical journal The Lancet has published the results of a two year health impact trial in Bangladesh. Less than 5% of studies submitted to this peer reviewed journal are published.

MUENSTER, Germany, Sept. 2, 2019 /PRNewswire/ --At the 9th AFM BioMed Conference, Bruker Corporation (Nasdaq: BRKR) today announced the release of the

EAST HANOVER, N.J., Sept. 2, 2019 /PRNewswire/ -- Novartis announced today results from two new clinical trials evaluating improvement in heart structure and function and long-term safety of Entresto® (sacubitril/valsartan) in patients with heart failure with reduced ejection fraction (HFrEF). Results suggest that Entresto, an essential treatme

NEW YORK, Aug. 31, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Oasmia Pharmaceutical AB from October 23, 2015 through July 9, 2019, inclusive (the "Class Period") of the important September 27, 2019 lead plaint

SUMMIT, N.J., Aug. 31, 2019 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today presented new scientific data at the Options for the Control of Influenza (OPTIONS X) Conference in Singapore that demonstrated circulating influenza B/Victoria (B/Vic) viruses are a closer match to cel

MILWAUKEE, Aug. 31, 2019 /PRNewswire/ -- FAB CBD, one of the most popular and trustworthy CBD hemp brands on the market, released two new flavors of their signature, organically grown hemp CBD oil: Vanilla and Berry.

SHANGHAI, Aug. 30, 2019 /PRNewswire/ -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to its investigational CAR-T cell therapy fully human anti-BCMA (B Cell Maturation Antigen) autologous chimeric antigen receptor (CAR) T Cells (ct053) fo

FORT LAUDERDALE, Fla., Aug. 30, 2019 /PRNewswire/ -- In observance of National Recovery Month 2019, Recovery Unplugged Treatment Centers has launched a dynamic and informative marketing

IRVINE, Calif., Aug. 30, 2019 /PRNewswire/ -- Herbalmax announces Reinvigorator Basic, as part of their expanded product-range of Nicotinamide Mononucleotide (NMN) -based nutraceuticals, enhanced with herbal compounds for metabolic optimization and healthy aging.